← All organizations

Clinigen, Inc.

For profitWebsite ↗

Also known as: Clinigen, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Oct 31, 2022

Timeline

1990s

May 5, 1992
aldesleukin— NDA Secondary Org

2000s

Jun 1, 2008
Clinigen, Inc.— Founded

Drugs by trial phase (9 distinct, 6 trials)

Phase 2 (4 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Other trials (3 own, 0 via acquisition)

Indications

Studied for

Melanoma

Marketed drugs (1)

aldesleukin

Recent trials (6)

NCT04750057CollaboratorN/A—
NCT04530994CollaboratorN/A—
NCT04960891CollaboratorN/A—
NCT05547321CollaboratorPhase 1Oct 31, 2022
NCT04562129CollaboratorPhase 2Sep 16, 2020
NCT03501381CollaboratorPhase 2May 24, 2018

Details

Founded: Burton Upon Trent, GB Jun 1, 2008
Last known activity: Oct 31, 2022